|
[Related PubMed/MEDLINE] Total Number of Papers: 7
|
|
|
[Display Entries]
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of
|
|
|
|
Abbreviation |
: DTaP-IPV |
Long Form |
: diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine |
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2019 |
A second dose of a measles-mumps-rubella vaccine administered to healthy four-to-six-year-old children: a phase III, observer-blind, randomized, safety and immunogenicity study comparing GSK MMR and MMR II with and without DTaP-IPV and varicella vaccines co-administration. |
MMR |
2 |
2019 |
Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) in Korean children. |
ADRs, AEs, PMS, SAEs |
3 |
2017 |
Elevated Immune Response Among Children 4 Years of Age With Pronounced Local Adverse Events After the Fifth Diphtheria, Tetanus, Acellular Pertussis Vaccination. |
AEs, IL, Th2 |
4 |
2014 |
Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. |
VSD |
5 |
2012 |
Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study. |
GMCs, Hib |
6 |
2011 |
Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea. |
FHA, PT |
7 |
1999 |
Immunogenicity and safety of a tetravalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine. |
--- |
|